The DOI matches its Crossref record, with a small difference in title or year; 98 of the 99 references it cites were found in a registry or an index.
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Open accessAbstract
Over the past decade, myocardial structure, cardiomyocyte function, and intramyocardial signaling were shown to be specifically altered in heart failure with preserved ejection fraction (HFPEF). A new paradigm for HFPEF development is therefore proposed, which identifies a systemic proinflammatory state induced by comorbidities as the cause of myocardial structural and functional alterations. The new paradigm presumes the following sequence of events in HFPEF: 1) a high prevalence of comorbidities such as overweight/obesity, diabetes mellitus, chronic obstructive pulmonary disease, and salt-sensitive hypertension induce a systemic proinflammatory state; 2) a systemic proinflammatory state causes coronary microvascular endothelial inflammation; 3) coronary microvascular endothelial inflammation reduces nitric oxide bioavailability, cyclic guanosine monophosphate content, and protein kinase G (PKG) activity in adjacent cardiomyocytes; 4) low PKG activity favors hypertrophy development and increases resting tension because of hypophosphorylation of titin; and 5) both stiff cardiomyocytes and interstitial fibrosis contribute to high diastolic left ventricular (LV) stiffness and heart failure development. The new HFPEF paradigm shifts emphasis from LV afterload excess to coronary microvascular inflammation. This shift is supported by a favorable Laplace relationship in concentric LV hypertrophy and by all cardiac chambers showing similar remodeling and dysfunction. Myocardial remodeling in HFPEF differs from heart failure with reduced ejection fraction, in which remodeling is driven by loss of cardiomyocytes. The new HFPEF paradigm proposes comorbidities, plasma markers of inflammation, or vascular hyperemic responses to be included in diagnostic algorithms and aims at restoring myocardial PKG activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The lessened secretion of inflammatory adipocytokines might act to alleviate coronary endothelial inflammation with secondary beneficial effects on microvascular rarefaction and myocardial fibrosis, 2 important mechanisms in the pathogenesis of HFpEF.46–48”
From Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity (2025) · cites this paper as [48]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Obesity and diabetes create a pro-inflammatory state and promote endothelial and coronary microvascular dysfunction. 1,7,8”
The cited source says what the claim attributes to it.
In the citing paper
“Obesity, diabetes, and HF result in pro-inflammatory states, 7,31-34 and each are risk factors for infectious disease complications, an important cause of morbidity and mortality in these patient groups.”
In the citing paper
“Inflammation due to sarcopenic obesity results in reduced NO, cyclic guanosine monophosphate (cGMP), and protein kinase G (PKG) activity in cardiomyocytes, leading to LV hypertrophy and stiffness [120].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [120]
In the citing paper
“Inhibition of systemic metabolic inflammation with glucose-lowering drugs is thought to enhance endothelial and cardiomyocyte function”
From The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF (2023) · cites this paper as [70]
In the citing paper
“Indirectly, through a paracrine endothelial signaling, hyperglycemia causes a mitochondrial hyper-production of superoxide, with impaired activation of endothelial nitric oxide synthase.”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [67]
In the citing paper
“As a result, the impaired bioavailability in nitric oxide impairs its downstream cGMP protein kinase G (PKG) pathway in cardiomyocytes which become hypertrophied and stiffened [65,67].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R., Ferdinand, K., Taylor, M., Adams, K., Sabolinski, M., Worcel, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042934 · Cited by 1,773
Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension
Ganau, A., Devereux, R. B., Roman, M. J., SIMONE, G. D., Pickering, T. G., Saba, P. S., Vargiu, P., Simongini, I., & LARAGH, J. H. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90617-v · Cited by 1,594
Zile, M. R., Baicu, C. F., & Gaasch, W. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032566 · Cited by 1,577
Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
Lam, C. S. P., Roger, V. L., Rodeheffer, R. J., Borlaug, B. A., Enders, F., & Redfield, M. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.051 · Cited by 1,345
Torre-Amione, G., Kapadia, S., Benedict, C., Oral, H., Young, J. B., & Mann, D. L. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00589-7 · Cited by 1,211
Solomon, S. D., Zile, M. R., Pieske, B. M., Voors, A. A., Shah, A. M., Kraigher‐Krainer, E., Shi, V. C., Bransford, T. L., Takeuchi, M., Gong, J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61227-6 · Cited by 1,171
Cited by
Sorted by citations
Items 101–200 of 1,005
Pre-Clinical Diastolic Dysfunction
Wan, S., Vogel, M. W., & Chen, H. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.063 · Cited by 336
Linke, W. A., & Hamdani, N. (2014) · Circulation Research · doi:10.1161/circresaha.114.301286 · Cited by 337
Gutterman, D. D., Chabowski, D. S., Kadlec, A. O., Durand, M. J., Freed, J. K., Ait‐Aissa, K., & Beyer, A. (2016) · Circulation Research · doi:10.1161/circresaha.115.305364 · Cited by 336
Developing Therapies for Heart Failure With Preserved Ejection Fraction
Butler, J., Fonarow, G. C., Zile, M. R., Lam, C. S. P., Roessig, L., Schelbert, E. B., Shah, S. J., Ahmed, A., Bonow, R. O., Cleland, J. G. F., et al. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2013.10.006 · Cited by 339
Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction
Obokata, M., Reddy, Y. N. V., & Borlaug, B. A. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.12.034 · Cited by 324
Kolijn, D., Pabel, S., Tian, Y., Lódi, M., Herwig, M., Carrizzo, A., Zhazykbayeva, S., Kovács, Á., Fülöp, G. Á., Falcão-Pires, I., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa123 · Cited by 323
Self-citationter Maaten, J. M., Damman, K., Verhaar, M. C., Paulus, W. J., Duncker, D. J., Cheng, C., van Heerebeek, L., Hillege, H. L., Lam, C. S. P., Navis, G. J., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.497 · Cited by 323
Self-citationKosiborod, M., Deanfield, J. E., Pratley, R. E., Borlaug, B. A., Butler, J., Davies, M. J., Emerson, S. S., Kahn, S. E., Kitzman, D. W., Lingvay, I., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01643-x · Cited by 331
Mitochondrial reactive oxygen species production and elimination
Nickel, A. G., Kohlhaas, M., & Maack, C. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.03.011 · Cited by 334
Zhang, Y., Yin, K., Wang, D., Wang, Y., Lu, H., Zhao, H., & Xing, M. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.156727 · Cited by 322
Gorter, T. M., Hoendermis, E. S., van Veldhuisen, D. J., Voors, A. A., Lam, C. S. P., Geelhoed, B., Willems, T. P., & van Melle, J. P. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.630 · Cited by 308
Suthahar, N., Meijers, W. C., Silljé, H. H. W., & de Boer, R. A. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0343-y · Cited by 307
Tromp, J., Westenbrink, B. D., Ouwerkerk, W., van Veldhuisen, D. J., Samani, N. J., Ponikowski, P. P., Metra, M., Anker, S. D., Cleland, J. G. F., Dickstein, K., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.06.050 · Cited by 312
Prevalence of Unrecognized Heart Failure in Older Persons with Shortness of Breath on Exertion
van Riet, E. E. S., Hoes, A. W., Limburg, A., Landman, M. A. J., van der Hoeven, H., & Rutten, F. H. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.110 · Cited by 304
Taqueti, V. R., Shaw, L. J., Cook, N. R., Murthy, V. L., Shah, N. R., Foster, C. R., Hainer, J. M., Blankstein, R., Dorbala, S., & Carli, M. F. D. (2016) · Circulation · doi:10.1161/circulationaha.116.023266 · Cited by 300
Obesity and Heart Failure: Focus on the Obesity Paradox
Carbone, S., Lavie, C. J., & Arena, R. A. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.11.001 · Cited by 298
Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction
Hahn, V. S., Knutsdottir, H., Luo, X., Bedi, K., Margulies, K. B., Haldar, S. M., Stolina, M., Yin, J., Khakoo, A. Y., Vaishnav, J., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050498 · Cited by 291
Knowledge Gaps in Cardiovascular Care of the Older Adult Population
Rich, M. W., Chyun, D. A., Skolnick, A. H., Alexander, K. P., Forman, D. E., Kitzman, D. W., Maurer, M. S., McClurken, J. B., Resnick, B. M., Shen, W. K., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.004 · Cited by 289
Metabolic inflammation in heart failure with preserved ejection fraction
Schiattarella, G. G., Rodolico, D., & Hill, J. A. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa217 · Cited by 284
Hallmarks of cardiovascular ageing
Abdellatif, M., Rainer, P. P., Sedej, S., & Kroemer, G. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00881-3 · Cited by 305
Heart failure with preserved ejection fraction: everything the clinician needs to know
Campbell, P. C., Rutten, F. H., Lee, M. M. Y., Hawkins, N. M., & Petrie, M. C. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02756-3 · Cited by 294
Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout
Hansildaar, R., Vedder, D., Baniaamam, M., Tausche, A.-K., Gerritsen, M., & Nurmohamed, M. T. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30221-6 · Cited by 278
Nakamura, K., Miyoshi, T., Yoshida, M., Akagi, S., Saito, Y., Ejiri, K., Matsuo, N., Ichikawa, K., Iwasaki, K., Naito, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073587 · Cited by 290
Kao, D. P., Lewsey, J., Anand, I. S., Massie, B. M., Zile, M. R., Carson, P. E., McKelvie, R. S., Michel Komajda, N., McMurray, J. J. V., & Lindenfeld, J. M. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.327 · Cited by 276
Konstam, M. A., & Abboud, F. M. (2017) · Circulation · doi:10.1161/circulationaha.116.025795 · Cited by 276
Left Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure
Nevers, T. A., Salvador, A. M., Grodecki‐Pena, A., Knapp, A., Velázquez, F., Aronovitz, M. J., Kapur, N. K., Karas, R. H., Blanton, R. M., & Alcaide, P. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002225 · Cited by 281
Hunter, W. G., Kelly, J. P., McGarrah, R. W., Khouri, M. G., Craig, D. M., Haynes, C. S., Ilkayeva, O., Stevens, R. D., Bain, J. R., Muehlbauer, M. J., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003190 · Cited by 274
Arterial Stiffening With Exercise in Patients With Heart Failure and Preserved Ejection Fraction
Reddy, Y. N. V., Andersen, M. J., Obokata, M., Koepp, K. E., Kane, G. C., Melenovsky, V., Olson, T. P., & Borlaug, B. A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.029 · Cited by 262
Borlaug, B. A., Anstrom, K. J., Lewis, G. D., Shah, S. J., Levine, J. A., Koepp, G. A., Givertz, M. M., Felker, G. M., LeWinter, M. M., Mann, D. L., et al. (2018) · JAMA · doi:10.1001/jama.2018.14852 · Cited by 268
The continuous heart failure spectrum: moving beyond an ejection fraction classification
Triposkiadis, F. K., Butler, J., Abboud, F. M., Armstrong, P. W., Adamopoulos, S. N., Atherton, J. J., Backs, J., Bauersachs, J. K., Burkhoff, D., Bonow, R. O., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz158 · Cited by 266
Epicardial fat in heart failure patients with mid-range and preserved ejection fraction
van Woerden, G., Gorter, T. M., Westenbrink, B. D., Willems, T. P., van Veldhuisen, D. J., & Rienstra, M. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1283 · Cited by 265
Löfman, I. H., Szummer, K. E., Dahlström, U., Jernberg, T., & Lund, L. H. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.821 · Cited by 264
de Boer, R. A., Nayor, M. G., deFilippi, C. R., Enserro, D. M., Bhambhani, V., Kizer, J. R., Blaha, M. J., Brouwers, F. P. J., Cushman, M., Lima, J. A. C., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2017.4987 · Cited by 264
Domain Management Approach to Heart Failure in the Geriatric Patient
Gorodeski, E. Z., Goyal, P., Hummel, S. L., Krishnaswami, A., Goodlin, S. J., Hart, L. L., Forman, D. E., WENGER, N. K., Kirkpatrick, J. N., & Alexander, K. P. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.059 · Cited by 266
Wijk, S. S., Tromp, J., Beussink‐Nelson, L., Hage, C., Svedlund, S., Saraste, A., Swat, S. A., Sanchez, C., Njoroge, J. N., Tan, R., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.045810 · Cited by 268
Immune Mechanisms in Heart Failure
Zhang, Y., Bauersachs, J. K., & Langer, H. F. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.942 · Cited by 260
Regulation of Coronary Blood Flow in Health and Ischemic Heart Disease
Duncker, D. J., Koller, Á., Merkus, D., & Canty, J. M. (2014) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2014.12.002 · Cited by 259
Rush, C. J., Berry, C., Oldroyd, K. G., Rocchiccioli, P., Lindsay, M. M., Touyz, R. M., Murphy, C., Ford, T. J., Sidik, N. P., McEntegart, M. B., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.1825 · Cited by 262
Wijk, S. S., van Empel, V. P. M., Davarzani, N., Maeder, M. T., Handschin, R., Pfisterer, M. E., Rocca, H. B., & for the TIME-CHF investigators (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.414 · Cited by 258
Bonderman, D., Pretsch, I., Steringer‐Mascherbauer, R., Jansa, P., Rosenkranz, S., Tufaro, C., Bojic, A., Lam, C. S. P., Frey, R., Kilama, M. O., et al. (2014) · CHEST Journal · doi:10.1378/chest.14-0106 · Cited by 258
Hypertension and Heart Failure
Slivnick, J. A., & Lampert, B. C. (2019) · Heart Failure Clinics · doi:10.1016/j.hfc.2019.06.007 · Cited by 275
Zhang, Z., Tang, J., Song, J., Xie, M., Liu, Y., Dong, Z., Liu, X., Li, X., Zhang, M.-W., Chen, Y., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.01.020 · Cited by 256
Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction
Tromp, J., Khan, M. A. F., Klip, I. T., Meyer, S., de Boer, R. A., Jaarsma, T., Hillege, H. L., van Veldhuisen, D. J., van der Meer, P., & Voors, A. A. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.003989 · Cited by 257
Myocardial ischemia and coronary disease in heart failure
Pagliaro, B., Cannata, F., Stefanini, G. G., & Bolognese, L. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09831-z · Cited by 251
2024 Clinical practice guidelines for Chronic heart failure
Galyavich, A. S., Tereshchenko, S. N., Uskach, T. M., Ageev, F. T., Aronov, D. M., Arutyunov, G. P., Begrambekova, Y. L., Belenkov, Y. N., Boytsov, S. A., Bubnova, M. G., et al. (2024) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2024-6162 · Cited by 251
Maack, C., Lehrke, M., Backs, J., Heinzel, F. R., Hulot, J., Marx, N., Paulus, W. J., Rossignol, P., Taegtmeyer, H., Bauersachs, J. K., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy596 · Cited by 255
Self-citationKapil, V., Khambata, R. S., Jones, D. A., Rathod, K., Primus, C., Massimo, G., Fukuto, J. M., & Ahluwalia, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019240 · Cited by 248
Zhao, L., Cheng, G., Jin, R., Afzal, M. R., Samanta, A., Xuan, Y., Girgis, M., Elias, H. K., Zhu, Y., Davani, A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.308688 · Cited by 245
Arterial stiffness and vascular aging: mechanisms, prevention, and therapy
Herzog, M. J., Müller, P., Lechner, K., Stiebler, M., Arndt, P., Kunz, M., Ahrens, D., Schmeißer, A., Schreiber, S., & Braun-Dullaeus, R. C. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02346-0 · Cited by 275
Saiki, H., Petersen, I. A., Scott, C. G., Bailey, K. R., Dunlay, S. M., Finley, R. R., Ruddy, K. J., Yan, E., & Redfield, M. M. (2017) · Circulation · doi:10.1161/circulationaha.116.025434 · Cited by 244
Autophagy in Cardiovascular Aging
Abdellatif, M., Sedej, S., Carmona-Gutierrez, D., Madeo, F., & Kroemer, G. (2018) · Circulation Research · doi:10.1161/circresaha.118.312208 · Cited by 239
Livshits, G., & Kalinkovich, A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100980 · Cited by 245
Sex-Specific Cardiovascular Structure and Function in Heart Failure with Preserved Ejection Fraction
Gori, M., Lam, C. S. P., Gupta, D. K., Santos, Â. B. S., Cheng, S. C., Shah, A. M., Claggett, B. L., Zile, M. R., Kraigher‐Krainer, E., Pieske, B. M., et al. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.67 · Cited by 237
Reframing the Association and Significance of Co-Morbidities in Heart Failure
Triposkiadis, F. K., Giamouzis, G., Parissis, J., Starling, R. C., Boudoulas, H. K., Skoularigis, J. S., Butler, J., & Filippatos, G. S. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.600 · Cited by 234
VCAM-1 as a predictor biomarker in cardiovascular disease
Troncoso, M. F., Ortiz‐Quintero, J., Garrido‐Moreno, V., Sanhueza‐Olivares, F., Guerrero‐Moncayo, A., Chiong, M., Castro, P., Garcı́a, L., Gabrielli, L., Corbalan, R. L., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166170 · Cited by 233
Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure
Njoroge, J. N., & Teerlink, J. R. (2021) · Circulation Research · doi:10.1161/circresaha.121.318186 · Cited by 240
Heart failure with preserved ejection fraction
Gladden, J. D., Linke, W. A., & Redfield, M. M. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1480-8 · Cited by 235
Abdominal Obesity Is Associated With an Increased Risk of All-Cause Mortality in Patients With HFpEF
Tsujimoto, T., & Kajio, H. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.1111 · Cited by 228
Sandireddy, R., Sakthivel, S., Gupta, P., Behari, J., Tripathi, M., & Singh, B. K. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1433857 · Cited by 235
MicroRNA Signatures Differentiate Preserved from Reduced Ejection Fraction Heart Failure
Watson, C. J., Gupta, S. K., O’Connell, E., Thum, S., Glezeva, N., Fendrich, J., Gallagher, J., Ledwidge, M. T., Grote-Levi, L. M., McDonald, K., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.244 · Cited by 230
Knowledge Gaps in Cardiovascular Care of the Older Adult Population
Rich, M. W., Chyun, D. A., Skolnick, A. H., Alexander, K. P., Forman, D. E., Kitzman, D. W., Maurer, M. S., McClurken, J. B., Resnick, B. M., Shen, W. K., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000380 · Cited by 225
Kiyuna, L. A., Albuquerque, R. P. E., Chen, C., Mochly‐Rosen, D., & Ferreira, J. C. B. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.019 · Cited by 231
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0002 · Cited by 275
Withaar, C., Meems, L. M. G., Markousis-Mavrogenis, G., Boogerd, C. J., Silljé, H. H. W., Schouten, E. M., Dokter, M. M., Voors, A. A., Westenbrink, B. D., Lam, C. S. P., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa256 · Cited by 223
BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection
Mills, R. J., Humphrey, S. J., Fortuna, P. R. J., Lor, M., Foster, S. R., Quaife-Ryan, G. A., Johnston, R. L., Dumenil, T. D., Bishop, C., Rudraraju, R., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.026 · Cited by 229
Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies
Omote, K., Verbrugge, F. H., & Borlaug, B. A. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-042220-022745 · Cited by 232
Jankauskas, S. S., Kansakar, U., Varzideh, F., Wilson, S. M., Mone, P., Lombardi, A., Gambardella, J., & Santulli, G. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154910 · Cited by 224
Borlaug, B. A., Koepp, K. E., & Melenovský, V. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.067 · Cited by 220
Silva, A. C., Pereira, C., Fonseca, A. C. R. G., Pinto‐do‐Ó, P., & Nascimento, D. S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.621644 · Cited by 231
Chirinos, J. A., Orlenko, A., Zhao, L., Basso, M., Cvijic, M. E., Li, Z., Spires, T. E., Yarde, M., Wang, Z., Seiffert, D., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.069 · Cited by 218
Eaton, C. B., Pettinger, M. B., Rossouw, J. E., Martin, L. W., Foraker, R. E., Quddus, A., Liu, S., Wampler, N. S., Wu, W.-C., Manson, J. E., et al. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002883 · Cited by 217
Gorter, T. M., Obokata, M., Reddy, Y. N. V., Melenovský, V., & Borlaug, B. A. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy331 · Cited by 217
Biological Phenotypes of Heart Failure With Preserved Ejection Fraction
Lewis, G. A., Schelbert, E. B., Williams, S. G., Cunnington, C., Ahmed, F. Z., McDonagh, T. A., & Miller, C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.006 · Cited by 220
Tuleta, I., & Frangogiannis, N. G. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166044 · Cited by 229
Nicotinamide for the treatment of heart failure with preserved ejection fraction
Abdellatif, M., Trummer-Herbst, V., Koser, F., Durand, S., Adão, R., Vasques‐Nóvoa, F., Freundt, J. K., Voglhuber, J., Pricolo, M. R., Kasa, M., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd7064 · Cited by 217
Cardio-Pulmonary-Renal Interactions
Husain‐Syed, F., McCullough, P. A., Birk, H., Renker, M., Brocca, A., Seeger, W., & Ronco, C. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.04.024 · Cited by 213
Gevaert, A. B., Shakeri, H., Leloup, A. J., Van Hove, C. E., De Meyer, G. R. Y., Vrints, C. J., Lemmens, K., & Van Craenenbroeck, E. M. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.116.003806 · Cited by 211
Rommel, K., von Roeder, M., Latuscynski, K., Oberueck, C., Blazek, S., Fengler, K., Besler, C., Sandri, M., Lücke, C., Gutberlet, M., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.02.018 · Cited by 211
Sorop, O., HEINONEN, I. H. A., van Kranenburg, M., van de Wouw, J., de Beer, V. J., Nguyen, I., Octavia, Y., van Duin, R. W. B., Stam, K., van Geuns, R., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy038 · Cited by 213
Self-citationArmstrong, P. W., Roessig, L., Patel, M. J., Anstrom, K. J., Butler, J., Voors, A. A., Lam, C. S. P., Ponikowski, P. P., Temple, T., Pieske, B. M., et al. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2017.08.013 · Cited by 210
Polyamines: Functions, Metabolism, and Role in Human Disease Management
Sagar, N. A., Tarafdar, S., Agarwal, S., Tarafdar, A., & Sharma, S. (2021) · Medical Sciences · doi:10.3390/medsci9020044 · Cited by 210
Cardiovascular Phenotype in HFpEF Patients With or Without Diabetes
Lindman, B. R., Dávila-Román, V. G., Mann, D. L., McNulty, S., Semigran, M. J., Lewis, G. D., de las Fuentes, L., Joseph, S. M., Vader, J., Hernandez, A. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.030 · Cited by 209
Coronary microvascular dysfunction in hypertrophy and heart failure
Camici, P. G., Tschöpe, C., Carli, M. F. D., Rimoldi, O. E., & Linthout, S. V. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa023 · Cited by 217
Self-citationNon-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction
Streng, K. W., Nauta, J. F., Hillege, H. L., Anker, S. D., Cleland, J. G. F., Dickstein, K., Filippatos, G. S., Lang, C. C., Metra, M., Ng, L. L., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.04.001 · Cited by 219
Michel Komajda, N., Isnard, R., Solal, A. C., Metra, M., Pieske, B. M., Ponikowski, P. P., Voors, A. A., Dominjon, F., Henon‐Goburdhun, C., Pannaux, M., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.876 · Cited by 206
Murine Models of Heart Failure With Preserved Ejection Fraction
Valero‐Muñoz, M., Backman, W., & Sam, F. (2017) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2017.07.013 · Cited by 217
Juni, R. P., Kuster, D. W. D., Goebel, M., Helmes, M., Musters, R. J. P., van der Velden, J., Koolwijk, P., Paulus, W. J., & van Hinsbergh, V. W. M. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.04.003 · Cited by 208
Self-citationSex Differences in Myocardial and Vascular Aging
Ji, H., Kwan, A. C., Chen, M. T., Ouyang, D., Ebinger, J. E., Bell, S. P., Niiranen, T., Bello, N. A., & Cheng, S. C. (2022) · Circulation Research · doi:10.1161/circresaha.121.319902 · Cited by 210
Costanzo, P., Cleland, J. G. F., Pellicori, P., Clark, A. L., Hepburn, D., Kilpatrick, E. S., Perrone-Filardi, P., Zhang, J., & Atkin, S. L. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1551 · Cited by 199
Heart failure with preserved ejection fraction: a clinical dilemma
Michel Komajda, N., & Lam, C. S. P. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu067 · Cited by 198
Damluji, A. A., Forman, D. E., van Diepen, S., Alexander, K. P., Page, R. L., II, Hummel, S. L., Menon, V., Katz, J. N., Albert, N. M., Afilalo, J., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000741 · Cited by 204
Vascular senescence in cardiovascular and metabolic diseases
Katsuumi, G., Shimizu, I., Yoshida, Y., & Minamino, T. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00018 · Cited by 196
Santos‐Gallego, C. G., Requena-Ibáñez, J. A., Antonio, R. S., García‐Ropero, Á., Ishikawa, K., Watanabe, S., Picatoste, B., Vargas-Delgado, A. P., Flores‐Umanzor, E., Sanz, J., et al. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.07.042 · Cited by 196
Borovac, J. A., D'Amario, D., Bozic, J., & Glavas, D. (2020) · World Journal of Cardiology · doi:10.4330/wjc.v12.i8.373 · Cited by 195
Tromp, J., Shen, L., Jhund, P. S., Anand, I. S., Carson, P. E., Desai, A. S., Granger, C. B., Michel Komajda, N., McKelvie, R. S., Pfeffer, M. A., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.05.052 · Cited by 195
Role of endothelial dysfunction in heart failure
Zuchi, C., Tritto, I., Carluccio, E., Mattei, C., Cattadori, G., & Ambrosio, G. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09881-3 · Cited by 208
Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
Sweeney, M., Corden, B., & Cook, S. A. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910865 · Cited by 202
Kitzman, D. W., & Shah, S. J. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.019 · Cited by 195
Heart Failure With Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models
Roh, J. D., Hill, J. A., Singh, A. S. C., Valero‐Muñoz, M., & Sam, F. (2022) · Circulation Research · doi:10.1161/circresaha.122.320257 · Cited by 202
Oxidative Stress and Antioxidant Treatments in Cardiovascular Diseases
Wang, W., & Kang, P. M. (2020) · Antioxidants · doi:10.3390/antiox9121292 · Cited by 199
Metadata
- Authors
- Paulus, W. J., & Tschöpe, C.
- Affiliations
- Amsterdam Cardiovascular Sciences (NL)
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Paulus, Walter J.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 62
- Issue
- 4
- Pages
- 263-271
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W164205712
- Cited by
- 3,564
- References
- 99
- Citations by year
- 2026: 351 · 2025: 334 · 2024: 320 · 2023: 298 · 2022: 331 · 2021: 364 · 2020: 348 · 2019: 253 · 2018: 225 · 2017: 228 · 2016: 222 · 2015: 148 · 2014: 117 · 2013: 19
- FWCI
- 28.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- European Commission
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- heart failure with preserved ejection fraction, systemic inflammation, comorbidities, nitric oxide bioavailability, protein kinase G, cardiomyocyte hypertrophy, diastolic dysfunction, left ventricular stiffness, interstitial fibrosis, cardiac remodeling, Laplace law, obesity, diabetes mellitus, chronic obstructive pulmonary disease, salt-sensitive hypertension
- MeSH terms
- Animals, Coronary Circulation, Endothelium, Vascular, Heart Failure, Humans, Inflammation, Microcirculation, Myocardium, Stroke Volume, Comorbidity, Ventricular Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
